Abacus Global Management, Inc. (ABX) Earnings Call Transcript & Summary

November 7, 2024

New York Stock Exchange US Financials Insurance earnings 25 min

Earnings Call Speaker Segments

Robert Phillips

executive
#1

Thanks, Operator. I also want to thank all of you for being on Abacus Life's third quarter 2024 earnings call. Joining me today are Jay Jackson, our Chairman and Chief Executive Officer, and Bill McCauley, our Chief Financial Officer. At 4:15 P.M. Eastern Time this afternoon, Abacus Life put out its third quarter 2024 results. On today's call, participants will have the opportunity to ask questions regarding our results. Prior to starting, Abacus Life directs participants on this call to the investor web page, where the press release, investor information, and SEC filings can be found, for a discussion of risks that may impact the business. Abacus Life specifically points participants to the presentation furnished today on Form 8-K with the Securities and Exchange Commission and wants to remind listeners that certain comments made today might include forward-looking statements and, therefore, will be subject to risks and uncertainties that, should they occur, could materially affect results. For further details on the risks, uncertainties, and assumptions tied to forward-looking statements, please see Abacus Life's public filings. Throughout the call, we will mention certain non-GAAP financial measures. While we believe these measures offer useful supplemental information concerning our financial performance, they are not recognized measures and lack standardized meanings under U.S. generally accepted accounting principles, or GAAP. Please consult our public filings for more information about our non-GAAP financial measures, including references to comparable GAAP measures. With that said, I would now like to hand the call over to Jay Jackson, Chairman and Chief Executive Officer.

Jay Jackson

executive
#2

Thank you, Rob, and I appreciate all of you taking the time to join us today and for your interest in Abacus — welcome to our third quarter 2024 earnings call. Once Bill and I finish our prepared remarks, we'll turn things over for your questions. Before getting into our results for the quarter, I want to acknowledge the enormous difficulties our communities in Florida have been dealing with because of the recent hurricanes. Everyone impacted is in our thoughts and prayers. We're grateful to all the first responders who have been working around the clock to help and to rebuild our communities. I'd also like to give special thanks to our Florida team, who put in tireless effort for Abacus and for our communities, even while the storms were affecting them personally. I couldn't be prouder of our whole team. Now to our results: we posted another quarter of strong, profitable growth, and at the same time we made meaningful headway on our strategic initiatives, which continues to establish Abacus Life as a top market maker and alternative asset manager. During the third quarter of 2024, total revenue rose 33% year over year, reaching $28.1 million, and we posted robust adjusted earnings — Adjusted EBITDA climbed 54% year over year to $16.7 million, while Adjusted Net Income rose 65% year over year to $14.9 million, equal to $0.20 per diluted share. Bill will join in a moment to walk through our third quarter financial performance in more depth. Beyond those outstanding quarterly financial results, we achieved major strides in our ABL Tech program, announced important acquisitions, reinforced our executive team, and introduced a new partnership along with a product offering. First, I'm delighted by how much progress we've made in moving our ABL Tech initiative forward since we formally introduced the program a mere eight months ago. ABL Tech launched with external clients in April, and in June we signed our first public pension client. This August, we also signed one of the biggest union pension funds in the United States. Our record in securing RFPs has been remarkable, and we keep beating the main incumbent vendors in this space. Of the five RFPs we've bid on so far, we came out on top in four, and we're waiting to hear about the last one. If we win that final RFP, we anticipate surpassing $1 million lives tracked by the first quarter of 2025. One of our RFPs fully demonstrated the value ABL Tech offers — it earned the top overall score in every category, including data security, product performance, price, and company evaluation, which highlights ABL Tech's clear, market-leading differentiation. As of October 31st, ABL Tech has 21 clients, while another 23 have either made firm commitments or are in active negotiations, spanning 23 states altogether. We anticipate that many, and possibly all, of those in our pipeline will be formally onboarded by the end of the first quarter of 2025, with contracts running three to five years that include automatic renewals once the initial term ends. As we look forward, our pipeline contains over 50 prospective customers who are at different points along the path of discovery, pricing, and proposals as we head into 2025. Drawing on decades of expertise with proprietary data sets related to health and longevity, ABL Tech develops customized offerings that provide enormous value to the pension fund and financial services sectors; over the long term, we anticipate ABL Tech will turn into a major contributor to our top-line growth. Furthermore, in Q3, we revealed 2 major acquisitions: Carlisle Management Company SCA and FCF Advisors. Carlisle Management, a top Luxembourg-based investment manager focused on life settlements, along with FCF Advisors, an asset manager and index provider that specializes in investment strategies centered on free cash flow, will collectively contribute roughly $2.6 billion in assets under management to our portfolio. Both transactions are anticipated to finalize before the close of Q4, pending regulatory approval. Our senior management team was also considerably bolstered by 2 important hires. First, we are delighted to welcome Corey McLaren as Managing Director of Capital Markets. Corey possesses extensive financial services experience, such as more than 15 years dedicated to life settlements and overseeing life settlement investment funds at Spearhead Capital, plus starting comparable funds at FDO Partners. Corey's profound sector insight and demonstrated success in business development and fund management will broaden our ability to push forward with our strategic objectives. In early October, we brought on Rob Phillips as our new Senior Vice President of Investor Relations and Corporate Affairs. Rob arrives with more than 30 years of invaluable experience in capital markets and investor relations, including leadership positions at NASDAQ, where he acted as a main liaison to public company executives and board members, along with considerable experience in institutional trading, brokerage, and regulatory affairs at the NYSE. Rob's knowledge will be crucial for enhancing our engagement with the investment and capital markets communities, propelling our strategic business initiatives, and backing our growth goals. We likewise achieved outstanding headway on new product efforts; during the quarter, Abacus teamed up with Lorisco to introduce PREADISAN, a groundbreaking health prediction and actuarial technology instrument. The novel risk score merges blood-based proteomic biomarker analysis with AI-driven models to evaluate mortality risk, delivering personalization and longevity forecasting. By combining Lorisco's state-of-the-art health prediction platform with Abacus's proficiency in life settlements and actuarial technology, we can furnish highly customized financial solutions for our clientele. Although this program remains in beta testing, this collaboration represents a major step forward in longevity-based financial planning, allowing us to deliver more precise and personalized services that account for both conventional actuarial factors and contemporary proteomic markers; regarding capital, our balance sheet and liquidity position continue to be robust. We put the $92 million of equity capital that we raised at the close of the second quarter to work successfully, and we kept a strong return on equity of 23% along with a return on invested capital of 21%; we're evaluating our capital choices, and since rates keep getting more attractive, we're looking at additional debt financing and possibly other ways to bring in more financing so we can capitalize on our strong market to buy policies at very attractive returns and back our growth outlook. Going forward, we're dedicated to keeping up our momentum and grabbing the huge opportunities in front of us to generate long-term profitable growth. By investing constantly and thoughtfully in product innovation and executing prudently, we keep strengthening Abacus as an innovative global alternative asset manager and market maker. With that, I'll turn it over now to our CFO, Bill McCauley, to go over the details of our third quarter results and financials.

Bill McCauley

executive
#3

Thanks for that, Jay, and hello everyone. As Jay said, Abacus turned in another strong quarter — growing revenue while remaining profitable. Our highly productive origination platform is still the primary driver of our results, and we're also expanding our other verticals, which will contribute to earnings down the road. During Q3 of 2024, we deployed $93.2 million of capital, versus $56.4 million in the same period a year ago, and the number of policies we bought rose 53%, reaching $278 million, up from $181 million the previous year. Thanks to our ongoing efforts to originate policies and deploy capital, Abacus had 532 policies on its balance sheet as of September 30th, 2024, valued at $274.4 million. Total revenue for the third quarter of 2024 rose 33%, reaching $28.1 million, versus $21.1 million a year prior. That improvement was driven largely by higher active management revenue. Turning back to expenses: our total operating expenses for the third quarter of 2024, excluding unrealized and realized gains and losses as well as the change in fair value of debt, were approximately $19.4 million, compared with $13.2 million a year earlier. The increase versus the prior-year period was driven by greater investments in SG&A. Notably, we increased our total employee headcount by 10% in the third quarter to support our growth initiatives through policy acquisition and active management, and through additional marketing to support our growth profile. Typically, it takes somewhere between 90 and 120 days before the company sees a return on what it invests in marketing. For the quarter, adjusted EBITDA rose 54%, reaching $16.7 million, up from $10.8 million in the same period last year. The adjusted EBITDA margin for the quarter was 59.2%, compared with 51.1% in the prior-year period. On a GAAP basis, net loss attributable to stockholders for the quarter was $5.1 million, whereas a year earlier there was net income of $0.9 million. That swing was primarily due to an $8.7 million non-cash increase in warrant liability during the third quarter of 2024, against a non-cash increase of $0.9 million the year before. If we look at adjusted results—meaning we strip out non-cash stock compensation, costs tied to acquiring businesses, amortization, and the change in fair value of warrant liability—net income came in at $14.9 million for the third quarter of 2024. That's a 65% increase from the $9 million recorded in the same period last year. Now let's go over balance sheet metrics: taking an annualized view for the three months that ended September 30th, 2024, adjusted return on equity stood at 23%, while adjusted return on invested capital was 21%. Both figures demonstrate how profitable our business model is. At September 30th, 2024, cash and cash equivalents totaled $19.4 million, balance sheet policy assets were $274.4 million, and long-term debt outstanding amounted to $166.5 million. To wrap up, we're happy with how strongly we did this quarter. We continue to deliver double-digit growth on the top line, and adjusted profitability remains solid. The expansion possibilities in front of us have us genuinely excited, and we're positioned well to execute on our long-term plans. On top of that, $7.8 million reflects where we stand. So with all of that said, I'll hand things back over to Jay Jackson, our CEO, to wrap up.

Jay Jackson

executive
#4

Thanks, Bill. So to wrap things up, as 2024 comes to a close, we're still really enthusiastic about the huge market opportunity ahead of us, and we're in a strong position to grab and expand our market share within this space. The path we're on toward turning into a global alternative asset manager is right on schedule, and the extensive longevity data we have is opening up fresh opportunities across a range of sectors, which boosts our growth prospects. We're dedicated to building on a track record of 20 years of financial success in order to deliver profitable growth over the long term. Once more, thank you everyone for being with us today, and we appreciate the interest you've shown in Abacus Life. With that, we're ready for your questions.

Crispin Love

analyst
#5

Thanks, and good evening to everybody. To start things off, Jay, could you share some thoughts on how the fourth quarter is trending up to this point, and then on seasonality in a wider sense? My recollection is that you previously mentioned how face value originated and capital put to work tend to run higher during Q4, since folks are making plans for next year and sitting down with advisors, and so on. So, to begin with, does that hold true, and have you witnessed that pattern during this year so far? Thanks very much.

Jay Jackson

executive
#6

Wonderful. Hello there, Crispin, and thank you. Yes, that pattern has kept going, from what we can tell. On our end, Abacus has now spent more than 20 years operating in this industry; and looking back, the fourth quarter in terms of where originations come from is, in my view, at the policy level, the policyholders themselves want to possibly wrap up this transaction before the calendar year ends; and because of that, our origination figures have tended to be stronger in Q4; that being said, Q3 was also quite strong for us. And I believe that may serve as yet another signal of what lies ahead. Still, when you consider how much our originations grew compared with a year earlier, I'd say we feel very, very bullish and definitely stay optimistic that this origination trajectory will keep heading in that same direction. So with Q4, it appears to be taking shape in the very same manner we've come to expect historically.

Crispin Love

analyst
#7

Good. Appreciate that, Jay — that's useful. Then, Bill, could you tell us the face value originated during Q3? I noticed the capital deployment figure, but I'm specifically after the originated face value amount.

Bill McCauley

executive
#8

For Q3, that came to $471.6 million.

Crispin Love

analyst
#9

Thank you.

Bill McCauley

executive
#10

You're welcome.

Andrew Kligerman

analyst
#11

Hey there, good evening. It's great to hear all of you. I guess I'll start with a question about the revenue from active management. Clearly, it was extremely robust this quarter at $27 billion. Over the coming four quarters, how do you expect that to unfold? Do you anticipate a fairly substantial increase? Any details you can share on that? After all, you put a great deal of capital to work.

Jay Jackson

executive
#12

Yes. Andrew, I appreciate you asking that, and it's good to hear from you too. I believe demand within our sector for buying these assets remains substantial. That was definitely the case during Q3, and we anticipate this pattern will persist into the foreseeable future. A few important developments currently underway are fueling part of this. From an investment standpoint, certain factors are definitely providing us with some tailwinds. One contributor is the quarter-point cut in rates we announced today. When your cost of capital declines, more investment flows into an asset class like ours, which historically delivers above-market returns that aren't correlated. So when we consider active management, this means we ought to keep seeing that pattern carry into 2025. We're therefore enthusiastic about our opportunities at present. We believe our positioning is extremely strong. And right now is a very shrewd and intelligent moment to deploy additional capital. We therefore enjoyed a productive Q3 when it came to allocating that capital. And as we just mentioned, we're definitely evaluating every possibility regarding what Q4 and Q1 will look like with respect to capital and active management. Still, the picture appears quite favorable at this time.

Andrew Kligerman

analyst
#13

And could we also go over the two far less significant revenue categories, portfolio servicing and origination revenue? Both came in somewhat below the prior-year quarter. Would you mind providing a bit of detail on each, along with your outlook for those two areas?

Jay Jackson

executive
#14

Alright. Our servicing revenue can rise or fall, since it depends on how busy we are handling both our own portfolio and other people's as well. So when cash moves into or out of anybody's portfolio — say, when they're offloading policies — your servicing revenue can take a hit in either direction on top of that. There's a client of ours on the servicing side that has basically been running down a portion of its portfolio. We've been placing those into the market with a lot of success. That has left some mark on servicing. Still, from where we sit, something on that servicing revenue line that has us quite energized is this: as our process with Carlisle Asset Management keeps moving forward, we believe we'll watch some meaningful servicing revenue keep building there as that process keeps getting integrated.

Andrew Kligerman

analyst
#15

Got it; and that closes at the end of the year, right?

Jay Jackson

executive
#16

Right. I won't commit to an exact date, but our expectation remains that this lands as a Q4 close.

Andrew Kligerman

analyst
#17

Got it; and then the origination revenue?

Jay Jackson

executive
#18

Right, so when it comes to origination revenue, the usual situation is this: if we lack initial capital, or if keeping that policy on our balance sheet isn't something we want to do, we may take that policy and sell it straight to that investor. There are several reasons that could be the case. Perhaps there's a size constraint. That doesn't imply anything about the policy's underlying basis that we either like or dislike. It could simply be that charging an origination fee and then selling directly to that third-party investor is a more efficient transaction. So it stands to reason that origination fee would decline as we purchase and retain a greater number of policies on our balance sheet and then, naturally, sell them off our balance sheet, as opposed to trading them—or instead of originating them for an origination fee straight to that third-party investor. That's the pattern you'd anticipate as we put more capital to work from our own balance sheet.

Andrew Kligerman

analyst
#19

Makes sense. Thank you.

Jay Jackson

executive
#20

Sure.

Mike Grondahl

analyst
#21

Thanks, guys. Has anything changed when it comes to the competitive landscape? And Jay, what would you call your top two objectives for 2025?

Jay Jackson

executive
#22

Sure thing. Let's kick off with a handful of the key priorities we have for 2025, and the first would be to continue expanding our education and awareness work through marketing of our underlying asset, helping people gain a better understanding of what our industry represents. Beyond that, what you saw was that on the acquisition side, groups that might look a bit different from simply sitting outside our industry — what we'd call adjacent industries — are something we're looking at very closely. So our intention is to keep growing the business and revenue model we already have while casting an eye toward those other revenue sources, which would include things like servicing and valuation. We're clearly excited about some of the developments starting to show up in the ABL Tech division when it comes to providing mortality verification services to pension funds and others. That's a 0.25 point.

Mike Grondahl

analyst
#23

Could you share a bit about what you've discovered up to now working with the bank partner, and how things are going with the new on-demand product?

Jay Jackson

executive
#24

Sorry, Mike, what did you say? I believe I didn't catch all of that.

Mike Grondahl

analyst
#25

The other thing I asked about was just how things look on the competition side.

Jay Jackson

executive
#26

Understood. When it comes to competing out there, my view is that within our sector, and in others too, when a company does well, it tends to lift everybody in that space. As we keep tracking this, I'd say the battle for market position in our business remains quite fierce. That leaves plenty of room for us given where we are; even now, we're the sole company in our sector that's publicly traded. In my view, that hands us a big edge, both when it comes to access to capital and in the way we get our message out straight to policyholders and to other institutions. We've been doing quite well telling our story to the other big origination and distribution sources we've mentioned. So looking at it from our vantage point, we're feeling very confident about our standing heading into 2025 and beyond; and we believe that edge will persist for that reason.

Mike Grondahl

analyst
#27

Great. Hey, thank you.

Jay Jackson

executive
#28

Absolutely.

Jay Jackson

executive
#29

Great. I appreciate all of you spending part of your night joining and hearing us out on this call. I hope a few things you come away with include this: one point we take a lot of pride in is that our expansion keeps going. We sit in an extremely strong spot for what's ahead both near term and over the long haul, and we anticipate those patterns will persist. As we put our capital to work, when we began examining items such as our EBITDA margin, now at nearly 60% in a quarter like Q3, that's something we feel a great deal of pride about and we're eager for this ongoing growth. So with everybody heading into the holidays, we're wishing you the happiest of holidays. And we can't wait to talk with you once more in the new year.

Operator

operator
#30

That wraps up this Abacus Life earnings call. We appreciate everyone joining us, and at this point you're free to leave the line.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Abacus Global Management, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to Abacus Global Management, Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Abacus Global Management, Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.